Unlinked anonymous HIV screening of pregnant women in a low-prevalence population

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 1, 1996, Pages 3-7

  Kantanen, Marja Leena ^a   Koskela, Pentti ^a   Leinikki, Pauli ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; FINLAND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOBLOTTING; MASS SCREENING; PREGNANCY;

EID: 0029984675     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027141     Document Type: Article

References (20)

1. Bernard R-P. Latin America and Europe first decade AIDS Atlas-GEO-2 cumulative incidence through September 1991. AIDS-Forschung 8: 127-150, 1993.
2. Leinikki P, Haikala O, Salminen M, Kantanen ML. HIV ja AIDS Suomessa [in Finnish]. Suomen Lääkärilehti 34: 3624-3629, 1994.
3. Parry JV, Mahoney A, Mortimer PP. Are seroepidemiological surveys for human immunodeficiency virus infection based on tests on pools of serum specimens accurate and cost-effective? Clin Diagn Virol 1: 167-168, 1993.
4. Behets F, Bertozzi S, Kasali M, Kashamuka M, Atikala L, Brown C, Ryder RW, Quinn TC. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. AIDS 4: 737-741, 1990.
5. Frösner GG, Dobler G, von Sonnenburg FJF. Cost reduction of unlinked testing for anti-HIV by investigation of pooled sera [short communication]. AIDS 4: 73-75, 1990.
6. Raboud JM, Sherlock C, Schechter MT, Lepine DG, O'Shaghnessy MV. Combining pooling and alternative algorithms in seroprevalence studies. J Clin Microbiol 31: 2298-2302, 1993.
7. Emmanuel JC, Bassett MT, Smith HJ, Jacobs JA. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. J Clin Pathol 41: 582-585, 1988.
8. Cahoon-Yong B, Chandler A, Livermore T, Gaudino J, Benjamin R. Sensitivity and specificity of pooled versus individual sera in a Human Immunodeficiency Virus antibody prevalence study. J Clin Microbiol 27: 1893-1895, 1989.
9. Aho K, Kantanen ML, Cantell K, Brink A, Pönkä A. Screening for HIV antibody during pregnancy [letter]. Lancet i: 921, 1987.
10. Kantanen ML, Cantell K, Aho k, Brink A, Pönkä A. Screening for HIV antibody during pregnancy. Serodiag Immunol Infect Dis 2: 113-115, 1988.
11. WHO Global Programme on AIDS (1990) Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I/HTLV-II. WHO Weekly Epidemiol Rec 37: 281-283, 1990.
12. Pönkä A, Cantell K, Kantanen ML, Leinikki P, Vartiainen E, Haikala O, Hovi S, Weckström P. Community screening for HIV infection in Finland [letter]. Am J Public Health 79: 522, 1989.
13. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV seroprevalence Research. Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence researh. Can Med Assoc J 146: 1743-1744, 1992.
14. Monzon OT, Paladin FJE, Dimaandal E, Balis AM, Samson C, Mitchell S. Relevance of antibody content and test format in HIV testing of pooled sera. AIDS 6: 43-48, 1993.
15. Mortimer JY. Saving tests by pooling sera - how great are the benefits? J Clin Pathol 33: 1120-1121, 1980.
16. Kline RL, Brothers TA, Brookmeyer R, Zeger S, Quinn TC. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera. J Clin Microbiol 27: 1449-1452, 1989.
17. AIDS Surveillance in Europe. Quarterly Report No 37. Saint-Maurice, France: European Centre for the Epidemiological Monitoring of AIDS, 1993.
18. Salminen M, Nykänen A, Brummer-Korvenkontio H, Kantanen ML, Liitsola K, Leinikki P. Molecular epidemiology of HIV-1 based on phylogenetic analysis of in vivo gag p7/p9 direct sequences. Virology 195: 185-194, 1993.
19. Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant. Morbid Mortal Wkly Rep 43: 285-287, 1994.
20. Wilfert CM. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Inf Dis 19: 664-666, 1994.